Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Investments: 2010-2015

Historic Long-Term Investments for Northwest Biotherapeutics (NWBO) over the last 5 years, with Dec 2015 value amounting to $349,000.

  • Northwest Biotherapeutics' Long-Term Investments fell 89.58% to $77,000 in Q2 2016 from the same period last year, while for Jun 2016 it was $77,000, marking a year-over-year decrease of 89.58%. This contributed to the annual value of $349,000 for FY2015, which is 80.17% down from last year.
  • According to the latest figures from FY2015, Northwest Biotherapeutics' Long-Term Investments is $349,000, which was down 80.17% from $1.8 million recorded in FY2014.
  • In the past 5 years, Northwest Biotherapeutics' Long-Term Investments registered a high of $1.8 million during FY2014, and its lowest value of $16,000 during FY2011.
  • In the last 2 years, Northwest Biotherapeutics' Long-Term Investments had a median value of $1.1 million in 2014 and averaged $1.1 million.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Long-Term Investments grew by 6.25% in 2012, and later tumbled by 80.17% in 2015.
  • Northwest Biotherapeutics' Long-Term Investments (Yearly) stood at $16,000 in 2011, then increased by 6.25% to $17,000 in 2012, then reached $1.8 million in 2014, then tumbled by 80.17% to $349,000 in 2015.